Clinical Study

Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease

Table 2

Serum IgG and IgG4 concentrations and IgG4/IgG4 ratio of patients with false-positive and false-negative diagnoses of IgG4-RD.

False positives

DiagnosisIgG (mg/dL)IgG4 (mg/dL)IgG4/IgG

(1) MCD7,0804,56064.4%
(2) MCD4,42069015.6%
(3) B-cell lymphoma2,51045618.2%
(4) MCD2,96029510.0%
(5) MCD2,47629511.9%
(6) B-cell lymphoma4,0102716.8%
(7) Scleritis2,9002328.0%
(8) Sarcoidosis1,38018913.7%
(9) Sjögren’s syndrome3,9201714.4%
(10) Malignant lymphoma1,9301417.3%

False negatives

 DiagnosisIgG(mg/dL)IgG4(mg/dL)IgG4/IgG

(1) IgG4-RD1,14912510.9%
(2) IgG4-RD1,21012310.2%
(3) IgG4-RD1,2281119.0%
(4) IgG4-RD1,2601068.4%

IgG4-RD: IgG4-related disease; MCD: multicentric Castleman’s disease.